Riga, Latvia

Boris Z Simkhovich

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Boris Z Simkhovich. Retrieved from https://idiyas.com/inventor/boris-z-simkhovich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Boris Z Simkhovich

Introduction: Boris Z Simkhovich is a notable inventor based in Riga, Latvia. He has made significant contributions to the field of organic chemistry, particularly through his innovative patent. His work focuses on developing novel compounds that have practical applications in medicine.

Latest Patents: Boris Z Simkhovich holds a patent for ethyl-3-(2-ethyl-2,2-dimethylhydrazinium)-propionate salts. This invention relates to the art of organic chemistry and presents compounds that possess an antiarrhythmic effect. The general formula for these compounds includes variations where X can be Cl, Br, or I. This patent highlights his expertise and commitment to advancing chemical research.

Career Highlights: Throughout his career, Boris has demonstrated a strong dedication to innovation in chemistry. His work has led to the development of compounds that can potentially improve medical treatments. With 1 patent to his name, he has established himself as a valuable contributor to the scientific community.

Collaborations: Boris has worked alongside notable colleagues, including Ma/Ya G Pshennikova and Ivars Y Kalvinsh. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion: Boris Z Simkhovich's contributions to organic chemistry and his innovative patent reflect his dedication to advancing the field. His work continues to inspire future research and development in medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…